Market Intelligence on House Dust Mite Allergy Industry 2025 – For Corporate Strategy and Innovation

 This report is designed for companies and decision-makers seeking actionable insights on market size, growth, trends, and competitive strategies to drive expansion and success in the House Dust Mite Allergy industry.

 
 What is the expected value of the house dust mite allergy market over the forecast period?
 The house dust mite allergy market size has grown rapidly in recent years. It will grow from $2.11 billion in 2024 to $2.39 billion in 2025 at a compound annual growth rate (CAGR) of 13.0%. The growth in the historic period can be attributed to increased awareness and education, advancements in diagnostic tools, research and clinical studies, healthcare infrastructure development, regulatory guidelines and standards.
 
 The house dust mite allergy market size is expected to see rapid growth in the next few years. It will grow to $4.1 billion in 2029 at a compound annual growth rate (CAGR) of 14.5%. The growth in the forecast period can be attributed to regulatory support and allergen labeling, rising allergy prevalence, telemedicine and remote care, increased focus on precision medicine, expansion of allergen-avoidance products. Major trends in the forecast period include public health awareness campaigns, integration of digital health solutions, focus on indoor environmental quality, growth in immunotherapy solutions, advancements in allergen avoidance products.
 
 Download Your Free Sample PDF:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=9304&type=smp
 
 What industry dynamics are acting as key growth drivers for the house dust mite allergy market?
 The prevalence of asthma diseases is expected to propel the growth of the house dust mite allergy market going forward. Asthma refers to a disease that causes one’s airways to constrict, swell and occasionally create more mucus that affects the lungs creating breathing issues. The patients suffering from asthma could easily affect by the surrounding dust which makes them more allergic and would increase their disease condition and need of several anti-allergic drugs, as a result, the increasing prevalence of asthma diseases increases the demand for house dust mite allergy treatments. For instance, in September 2024, according to the Asthma and Allergy Foundation of America, a US-based Community-based organization, in the U.S., around 10 people die from asthma daily, totaling 3,235 deaths in 2022. Most of these fatalities are preventable with proper treatment and care. Therefore, the prevalence of asthma diseases is driving the house dust mite allergy market.
 
 What are the fastest-growing segments in the house dust mite allergy market forecast period?
 The house dust mite allergy market covered in this report is segmented –
 
 1) By Product Type: Tablets, Nasal Drops, Injectable
 2) By Treatment Type: Medication, Immunotherapy, Nasal Irrigation, Other Types
 3) By Diagnosis: Skin Prick Test (SPT), Specific Immunoglobulin E (IgE) Blood Test, Other Diagnosis
 4) By Dosage Forms: Solid, Liquid
 5) By End Users: Hospitals, Homecare, Specialty Clinics, Other End Users
 
 Subsegments:
 1) By Tablets: Sublingual Tablets, Oral Tablets
 2) By Nasal Drops: Antihistamine Nasal Drops, Corticosteroid Nasal Drops
 3) By Injectable: Allergen Immunotherapy Injections, Corticosteroid Injections
 
 View The Full Market Report:
 https://www.thebusinessresearchcompany.com/report/house-dust-mite-allergy-global-market-report
 
 What are the key trends shaping the house dust mite allergy market in the forecast period?
 Major companies operating in the house dust mite allergy market are focusing on developing innovative solutions, such as sublingual tablets designed to treat house dust mite allergies to address the increasing prevalence of allergies. A sublingual tablet designed to treat house dust mite allergies refers to a type of immunotherapy that involves placing a tablet under the tongue, where it dissolves and delivers small doses of the allergen responsible for triggering the allergy. For instance, in January 2023, ALK-Abelló A/S, a Denmark-based pharmaceutical company, received FDA approval for ODACTRA, a sublingual tablet designed to treat house dust mite allergies in adolescents aged 12 to 17, expanding its previous indication for adults. This approval addresses a significant need, as nearly 50% of allergy sufferers are sensitive to house dust mites. Clinical trials demonstrated that ODACTRA effectively reduced allergy symptoms, with a safety profile similar to that observed in adults. While the treatment is generally well-tolerated, patients are advised to have auto-injectable epinephrine on hand due to the potential for severe allergic reactions.
 
 Which major players hold significant market share in the house dust mite allergy sector?
 Major companies operating in the house dust mite allergy market include Allergy Therapeutics Plc, Bayer AG, Catalent Inc., GSK Plc, Merz Pharma GmbH & Co KGaA, Sanofi S A, Shionogi & Co. Ltd., Stallergenes Greer International AG, Merck & Co. Inc., Torii Pharmaceutical Co. Ltd., Ergomed PLC, DMS Group, HAL Allergy Group, Trio Lifescience Private Limited, Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, Johnson and Johnson Inc., Circassia Pharmaceuticals Plc, Biomay Ag, GlaxoSmithKline
 
 Which regional segments are forecasted to witness the fastest growth in the house dust mite allergy market?
 North America was the largest region in the house dust mite allergy market in 2024. Asia-pacific is expected to be the fastest-growing region in the house dust mite allergy market report during the forecast period. The regions covered in the house dust mite allergy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
 
 How Can Companies Use The House Dust Mite Allergy Market Report to Drive Business Results?
 This report provides actionable insights tailored for business use — not academic analysis. Companies can leverage the data to:
 • Time market entry or expansion using growth forecasts and CAGR trends.
 • Develop competitive products by tracking key technology shifts and user preferences.
 • Tailor regional strategies with in-depth geographic data and local market dynamics.
 • Benchmark and plan partnerships using competitive landscape insights.
 
 Purchase The Report And Get A Swift Delivery:
 https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9304
 
 Need Customized Data On House Dust Mite Allergy Market?
 For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you’re entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
 
 Request Customized Data:
 https://www.thebusinessresearchcompany.com/customise?id=9304&type=smp
 
 About The Business Research Company:
 
 With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
 
 Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
 
 Contact Us:
 
 The Business Research Company
 
 https://thebusinessresearchcompany.com/
 
 Europe: +44 207 1930 708
 
 Asia: +91 88972 63534
 
 Americas: +1 315 623 0293
 
 Email: info@tbrc.info
 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company